Experts say a new bivalent vaccine targeting both the original 2020 strain of COVID-19 and the Omicron variant could be a game-changer.
Key Points
- Moderna has received permission from the Therapeutic Goods Administration [[TGA]] to apply for provisional approval for its bivalent vaccine to be used in Australia.
- Moderna has received permission from the Therapeutic Goods Administration [[TGA]] to apply for provisional approval for its bivalent vaccine to be used in Australia.
- It takes 100 days to produce a new variant vaccine.
Share





